SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (1239)12/22/1997 4:20:00 PM
From: Bill Wexler  Read Replies (1) of 7041
 
<< By the time a drug reaches the NDA phase the approval rate probably reaches 85% - 90%. Probably 25%-50% go through the FDA smoothly,>>

This is horse manure. But in Zonagen's case, still irrelevant. Since their Phase II and III trails have failed (trust me - if the drug was truly effective, we would have seen 10 press releases by now), and the company is now going to do more testing, we can rest assured that an NDA will not be submitted anytime soon - if ever.

Zonagen is a scam and a fraud.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News